$326.45
+3.76 (+1.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+19.75%
1Y
+135.43%
YTD
+32.21%
Open$326.34
Previous Close$322.69
Day High$329.00
Day Low$320.34
52W High$382.54
52W Low$132.31
Volume—
Avg Volume486.2K
Market Cap9.65B
P/E Ratio42.90
EPS$7.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$263.07
Above
SMA 200
$186.47
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-73.4% upside
Current
$326.45
$326.45
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 384.25M | 971.92M | 894.90M |
| Net Income | 202.26M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 164.92M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |